PART I - FINANCIAL INFORMATION This section provides the unaudited condensed consolidated financial statements and management's discussion and analysis for the three months ended March 31, 2022 [Item 1. Financial Statements (unaudited)](index=5&type=section&id=Item%201.%20Financial%20Statements%20(unaudited)) This section presents the unaudited condensed consolidated financial statements for SCWorx Corp., including balance sheets, statements of operations, changes in stockholders' equity, and cash flows, along with detailed notes explaining the company's business, accounting policies, liquidity, and legal contingencies for the three months ended March 31, 2022, and 2021 [Consolidated Balance Sheets](index=6&type=section&id=Consolidated%20balance%20sheets%20as%20of%20March%2031%2C%202022%20(unaudited)%20and%20December%2031%2C%202021%20(audited)) The consolidated balance sheets show the company's financial position, with a notable decrease in cash and total stockholders' equity, alongside an increase in accounts receivable and total liabilities from December 31, 2021, to March 31, 2022 | Metric | March 31, 2022 | December 31, 2021 | | :-------------------------------- | :------------- | :---------------- | | Cash | **$8,293** | **$71,075** | | Accounts receivable - net | **$697,195** | **$464,851** | | Total current assets | **$981,641** | **$756,468** | | Total liabilities | **$3,137,016** | **$2,717,865** | | Total stockholders' equity | **$6,211,092** | **$6,405,070** | | Total assets | **$9,348,108** | **$9,122,935** | [Unaudited Consolidated Statements of Operations](index=7&type=section&id=Unaudited%20consolidated%20statements%20of%20operations%20for%20the%20three%20months%20ended%20March%2031%2C%202022%20and%202021) The company reported a reduced net loss for the three months ended March 31, 2022, compared to the same period in 2021, primarily due to a gain on forgiveness of a PPP loan, despite a decrease in revenue and an increase in operating loss | Metric | Three months ended March 31, 2022 | Three months ended March 31, 2021 | | :----------------------------------- | :-------------------------------- | :-------------------------------- | | Revenue | **$1,030,949** | **$1,148,257** | | Total operating expenses | **$1,797,090** | **$1,896,200** | | Loss from operations | **$(766,141)** | **$(747,943)** | | Gain on forgiveness of PPP loan | **$139,595** | **$-** | | Net loss | **$(626,546)** | **$(747,943)** | | Net loss per share, basic and diluted | **$(0.06)** | **$(0.07)** | [Unaudited Consolidated Statements of Changes in Stockholders' Equity](index=8&type=section&id=Unaudited%20consolidated%20statements%20of%20changes%20in%20stockholders'%20equity%20for%20the%20three%20months%20ended%20March%2031%2C%202022%20and%202021) Stockholders' equity decreased from December 31, 2021, to March 31, 2022, primarily due to the net loss, partially offset by stock-based compensation and shares issued for accounts payable settlement | Metric | Three Months Ended March 31, 2022 | | :------------------------------------ | :-------------------------------- | | Balances, December 31, 2021 (Total) | **$6,405,070** | | Shares issued as settlement of accounts payable | **83,954 shares** (**$85,000 value**) | | Shares issued for vested restricted stock units | **18,666 shares** | | Stock based compensation | **$347,568** | | Net Loss | **$(626,546)** | | Ending balance, March 31, 2022 (Total) | **$6,211,092** | [Unaudited Consolidated Statements of Cash Flows](index=9&type=section&id=Unaudited%20consolidated%20statements%20of%20cash%20flows%20for%20the%20three%20months%20ended%20March%2031%2C%202022%20and%202021) Cash used in operating activities significantly decreased in Q1 2022 compared to Q1 2021, while there were no investing or financing activities in Q1 2022, leading to a net decrease in cash | Metric | Three months ended March 31, 2022 | Three months ended March 31, 2021 | | :-------------------------------- | :-------------------------------- | :-------------------------------- | | Net cash used in operating activities | **$(62,782)** | **$(426,901)** | | Net cash used in investing activities | **$-** | **$-** | | Net cash provided by financing activities | **$-** | **$139,595** | | Net (decrease) increase in cash | **$(62,782)** | **$(287,306)** | | Cash, end of period | **$8,293** | **$89,119** | [Notes to Unaudited Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20unaudited%20condensed%20consolidated%20financial%20statements) These notes provide detailed explanations and disclosures for the unaudited condensed consolidated financial statements, covering the company's business, liquidity, significant accounting policies, and specific financial line items, offering context to the reported figures - Financial statements are prepared in accordance with U.S. GAAP and SEC rules, consolidating SCWorx and its wholly-owned subsidiaries[40](index=40&type=chunk) - The company applies fair value accounting using a **three-level hierarchy** for financial instruments[45](index=45&type=chunk) | Customer | Revenue (Q1 2022) | Revenue (Q1 2021) | Accounts Receivable (Mar 31, 2022) | Accounts Receivable (Dec 31, 2021) | | :--------- | :------------------ | :------------------ | :--------------------------------- | :--------------------------------- | | Customer A | **13%** | **8%** | **55%** | -% | | Customer B | **10%** | **9%** | **14%** | **9%** | | Customer C | **12%** | **5%** | **3%** | **13%** | | Customer D | **11%** | -% | **3%** | -% | | Customer E | -% | **26%** | -% | **21%** | - Allowance for doubtful accounts increased to **$468,611** as of March 31, 2022, from **$421,736** as of December 31, 2021[48](index=48&type=chunk) | Inventory Component | March 31, 2022 | December 31, 2021 | | :------------------ | :------------- | :---------------- | | Inventory | **$523,440** | **$523,440** | | Allowance for obsolescence | **$(366,840)** | **$(366,840)** | | Net inventory value | **$156,600** | **$156,600** | - Revenue recognition follows Topic **606**, identifying distinct performance obligations such as Data Normalization, SaaS, Maintenance, and Professional Services, with SaaS and Maintenance revenues recognized ratably over contract terms[53](index=53&type=chunk)[55](index=55&type=chunk)[59](index=59&type=chunk) - Deferred revenue (remaining performance obligations) increased to **$764,500** as of March 31, 2022, from **$472,750** as of December 31, 2021[65](index=65&type=chunk)[69](index=69&type=chunk) - Stock-based compensation expense is measured at grant date fair value using a Black-Scholes model and recognized over the vesting period[76](index=76&type=chunk) [Note 1. Description of Business](index=10&type=section&id=Note%201.%20Description%20of%20Business) SCWorx provides health information technology solutions for healthcare providers, focusing on data normalization, interoperability, and big data analytics. The COVID-19 pandemic adversely impacted customer acquisition and service utilization, leading the company to temporarily engage in PPE sales as an intermediary - SCWorx offers health information technology solutions and services to improve healthcare processes and information flow within hospitals, including data normalization, interoperability, and big data analytics[28](index=28&type=chunk)[29](index=29&type=chunk) - The company's software modules include virtualized Item Master File repair, CDM management, contract management, and big data analytics modeling[30](index=30&type=chunk) - Solutions are delivered via a Software-as-a-Service (SaaS) model, typically with **three-to-five-year** contracted terms, hosted in SCWorx data centers (AWS or RackSpace)[32](index=32&type=chunk) - The COVID-19 pandemic adversely impacted new customer acquisition and customers' ability to focus resources on expanding SCWorx services, affecting growth prospects[33](index=33&type=chunk)[34](index=34&type=chunk) - To mitigate revenue impacts,

Part I [Business](index=5&type=section&id=Item%201.%20Business) SCWorx provides healthcare IT solutions for data normalization, interoperability, and big data analytics, helping clients reduce costs and improve accuracy - The company's primary business is providing a SaaS platform to healthcare providers for data management, aiming to integrate supply chain, financial, and clinical systems to improve efficiency and reduce costs[20](index=20&type=chunk)[21](index=21&type=chunk) - SCWorx's software solutions are delivered on a SaaS model, typically with three-to-five-year contracts, and are hosted on third-party data centers like AWS or RackSpace[29](index=29&type=chunk) - In response to the COVID-19 pandemic, the company established a subsidiary, Direct-Worx, LLC, to sell PPE and rapid test kits, but this venture faced significant difficulties, generated minimal sales, and is no longer actively pursued[33](index=33&type=chunk)[34](index=34&type=chunk) - The company's CageTix ticketing platform for regional MMA promotions was paused due to COVID-19 restrictions on large gatherings[30](index=30&type=chunk)[47](index=47&type=chunk) [Risk Factors](index=15&type=section&id=Item%201A.%20Risk%20Factors) The company faces significant risks including going concern doubt, operational disruptions from COVID-19, high customer concentration, and internal control weaknesses - Auditors have expressed substantial doubt about the company's ability to continue as a going concern due to recurring operating losses and a working capital deficit[81](index=81&type=chunk)[82](index=82&type=chunk) Financial Health Indicators (as of Dec 31, 2021) | Metric | Value | | :--- | :--- | | Net Loss (FY 2021) | $3,814,468 | | Net Loss (FY 2020) | $7,402,350 | | Accumulated Deficit | $24,011,291 | | Working Capital Deficit | $1,527,830 | - The company has a high customer concentration, with two customers accounting for **19% and 13% of revenue in 2021**, and two customers accounting for **22% and 17% in 2020**[91](index=91&type=chunk) - A material weakness in internal controls over financial reporting has been identified, related to a lack of proper segregation of duties[125](index=125&type=chunk) - The company's common stock is at risk of delisting from Nasdaq for trading below the minimum **$1.00 bid price requirement**[117](index=117&type=chunk) [Properties](index=30&type=section&id=Item%202.%20Properties) The company does not own real property, operating from a leased New York office on a month-to-month basis after terminating a previous lease - The company does not own any real estate and operates from a leased office in New York under a month-to-month agreement[156](index=156&type=chunk) [Legal Proceedings](index=30&type=section&id=Item%203.%20Legal%20Proceedings) The company settled securities class action and derivative lawsuits but remains under SEC investigation following a Wells Notice related to a 2020 press release - The Consolidated Securities Class Action was settled in February 2022, involving a cash payment from insurers, a transfer of **100,000 shares** from the former CEO, and the issuance of **$600,000 worth of common stock** by the company[161](index=161&type=chunk) - The Consolidated Derivative Action was also settled in February 2022, with terms including a cash payment from insurers for plaintiffs' legal fees and the company's adoption of corporate governance reforms[165](index=165&type=chunk) - The SEC is continuing an investigation related to the April 2020 press release, with the company receiving a Wells Notice in December 2021 indicating a potential enforcement action for alleged violations[166](index=166&type=chunk) - A lawsuit from a former employee, David Klarman, seeking **$400,000** for breach of an employment agreement was settled in December 2021 for **$100,000 worth of SCWorx shares**[170](index=170&type=chunk) Part II [Market for Common Equity and Related Stockholder Matters](index=33&type=section&id=Item%205.%20Market%20for%20the%20Registrant's%20Common%20Equity,%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's common stock trades on Nasdaq, experiencing volatility, and the company has never paid cash dividends, intending to retain earnings for growth Common Stock Price Range (2021 vs. 2020) | Quarter | 2021 High ($) | 2021 Low ($) | 2020 High ($) | 2020 Low ($) | | :--- | :--- | :--- | :--- | :--- | | Q1 | 3.08 | 1.28 | 3.14 | 1.55 | | Q2 | 2.49 | 1.28 | 12.02 | 2.09 | | Q3 | 5.00 | 1.45 | 5.75 | 1.29 | | Q4 | 2.28 | 1.16 | 2.22 | 1.03 | - The company has never paid cash dividends and does not plan to in the foreseeable future, retaining earnings to finance growth[177](index=177&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=33&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) In 2021, SCWorx's revenue decreased by **11% to $4.6 million**, while net loss narrowed to **$3.8 million** due to reduced expenses, but the company faces substantial doubt about its going concern ability Results of Operations (2021 vs. 2020) | Metric | 2021 ($) | 2020 ($) | Change ($) | | :--- | :--- | :--- | :--- | | Revenue | 4,632,529 | 5,213,118 | (580,589) | | Cost of Revenues | 2,782,509 | 3,515,279 | (732,770) | | General & Administrative | 5,664,488 | 7,742,850 | (2,078,362) | | Net Loss | (3,814,468) | (7,402,350) | 3,587,882 | - The decline in 2021 revenue was primarily due to a **~$410,000 decrease in PPE sales** and a **~$125,000 decrease** from the suspended Cagetix operations[242](index=242&type=chunk) - General and administrative expenses decreased by **$2.1 million**, driven by lower stock-based compensation (**~$600k**) and reduced legal and professional fees (**~$1.08M**)[244](index=244&type=chunk) - The company has substantial doubt about its ability to continue as a going concern, citing a working capital deficit of **$1,527,830**, an accumulated deficit of **$24,011,291**, and a net loss of **$3,814,468** for the year ended Dec 31, 2021[246](index=246&type=chunk) Cash Flow Summary (2021 vs. 2020) | Activity | 2021 ($) | 2020 ($) | | :--- | :--- | :--- | | Net cash used in operating activities | (1,069,945) | (959,070) | | Net cash used in investing activities | 0 | 0 | | Net cash provided by financing activities | 764,595 | 847,542 | [Changes in and Disagreements with Accountants](index=47&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) The company experienced multiple auditor changes, with Sadler Gibb terminating its engagement due to reliance issues and disagreements, leading to the appointment of BF Borgers CPA PC - Withum Smith + Brown discontinued its audit services in October 2020 for reasons unrelated to the company's financials[267](index=267&type=chunk) - Sadler Gibb & Associates, LLC, the successor firm, terminated its engagement in April 2021, stating it could not rely on management's representations and citing disputed disagreements on accounting matters[272](index=272&type=chunk) - BF Borgers CPA PC was appointed as the new independent registered public accounting firm in April 2021[273](index=273&type=chunk) [Controls and Procedures](index=48&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded that disclosure controls were ineffective as of December 31, 2021, due to a material weakness in internal controls related to a lack of segregation of duties - The CEO and CFO concluded that disclosure controls were not effective as of December 31, 2021[275](index=275&type=chunk) - A material weakness was identified in internal controls due to a lack of segregation of duties, with remediation efforts expected to be resolved during 2022[276](index=276&type=chunk) Part III [Directors, Executive Officers and Corporate Governance](index=49&type=section&id=Item%2010.%20Directors,%20Executive%20Officers%20and%20Corporate%20Governance) The company's leadership includes President & CEO Timothy Hannibal and CFO Chris Kohler, with a five-member Board of Directors, a majority of whom are independent and serve on established committees Executive Officers and Directors | Name | Position(s) | | :--- | :--- | | Timothy A. Hannibal | President & Chief Executive Officer | | Chris Kohler | Chief Financial Officer | | Alton Irby | Director | | John Ferrara | Director | | Steven Horowitz | Director | | Steven Wallitt | Director | - The Board of Directors has three standing committees: Audit, Compensation, and Nominating and Governance[304](index=304&type=chunk) - All directors except for CEO Timothy Hannibal are considered independent under Nasdaq listing standards[337](index=337&type=chunk) [Executive Compensation](index=52&type=section&id=Item%2011.%20Executive%20Compensation) In 2021, CEO Timothy Hannibal received **$551,013** in total compensation, including **$319,350** in stock awards, while director compensation consisted entirely of stock awards 2021 Executive Compensation Summary | Name and Principal Position | Salary ($) | Stock Awards ($) | Total ($) | | :--- | :--- | :--- | :--- | | Timothy Hannibal (President, CEO) | 225,000 | 319,350 | 551,013 | | Chris Kohler (CFO) | 90,000 | 185,828 | 275,828 | 2021 Director Compensation Summary | Name | Fees Earned or Paid in Cash ($) | Stock Awards ($) | Total ($) | | :--- | :--- | :--- | :--- | | Alton Irby | - | 157,000 | 157,000 | | John Ferrara | - | 124,584 | 124,584 | | Steven Horowitz | - | 124,584 | 124,584 | | Steven Wallitt | - | 157,000 | 157,000 | [Security Ownership](index=54&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%20and%20Related%20Stockholder%20Matters) As of March 31, 2022, directors and executive officers collectively owned **10.0%** of outstanding common stock, with CEO Timothy Hannibal holding **6.6%** and former CEO Marc Schessel holding **9.3%** - As of March 31, 2022, there were **11,383,454 shares** of common stock outstanding[325](index=325&type=chunk) Beneficial Ownership (as of March 31, 2022) | Name | Total Shares | Percentage Ownership | | :--- | :--- | :--- | | Timothy Hannibal (CEO) | 805,141 | 6.6% | | Steven Wallitt (Director) | 201,120 | 1.8% | | Marc Schessel (Former CEO) | 1,106,606 | 9.3% | | Directors & Executive Officers as a Group (6 persons) | 1,248,095 | 10.0% | - The company's Amended and Restated 2016 Equity Incentive Plan allows for the issuance of up to **5,000,000 shares**[328](index=328&type=chunk) [Certain Relationships and Related Transactions](index=56&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions,%20and%20Director%20Independence) The company owed **$153,838** to officers at year-end 2021, and its former CEO advanced **$100,000** in cash and entered a **$295,000** annual consulting agreement - The company's former CEO, Marc Schessel, advanced **$100,000** in cash to the company in September 2021 for short-term capital needs[334](index=334&type=chunk) - Upon his departure as CEO in January 2021, Marc Schessel entered into a two-year consulting agreement with the company at an annual fee of **$295,000**[335](index=335&type=chunk) [Principal Accountant Fees and Services](index=56&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) In 2021, the company paid a total of **$212,450** in audit and other fees to its accounting firms, with BF Borgers CPA PC billing **$164,800** for audit services Accountant Fees (2021) | Firm | Audit Fees ($) | All Other Fees ($) | Total ($) | | :--- | :--- | :--- | :--- | | BF Borgers CPA PC | 164,800 | - | 164,800 | | Sadler Gibb | 40,000 | - | 40,000 | | Withum | - | 7,650 | 7,650 | Part IV [Exhibits and Financial Statement Schedules](index=59&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section presents the company's consolidated financial statements for 2021 and 2020, including the auditor's report which expresses substantial doubt about the company's going concern ability - The Report of Independent Registered Public Accounting Firm (BF Borgers CPA PC) contains a paragraph highlighting substantial doubt about the Company's ability to continue as a going concern due to significant operating losses[360](index=360&type=chunk) Consolidated Balance Sheet Highlights (As of Dec 31) | Account | 2021 ($) | 2020 ($) | | :--- | :--- | :--- | | Cash | 71,075 | 376,425 | | Total Current Assets | 756,468 | 2,184,651 | | Goodwill | 8,366,467 | 8,366,467 | | Total Assets | 9,122,935 | 10,627,274 | | Total Current Liabilities | 2,284,298 | 4,599,286 | | Total Liabilities | 2,717,865 | 4,893,258 | | Total Stockholders' Equity | 6,405,070 | 5,734,016 | Consolidated Statement of Operations Highlights (Year Ended Dec 31) | Account | 2021 ($) | 2020 ($) | | :--- | :--- | :--- | | Revenue | 4,632,529 | 5,213,118 | | Loss from Operations | (3,814,468) | (6,045,011) | | Net Loss | (3,814,468) | (7,402,350) | | Net Loss Per Share | (0.36) | (0.82) |

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (State or other jurisdiction of incorporation or organization) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 47-5412331 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-37899 SCWORX CORP. (Exact nam ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File Number: 001-37899 SCWORX CORP. (Exact name of registrant as specified in its charter) Delaware 47-5412331 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-37899 SCWORX CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37899 SCWORX CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 47-5412331 | | --- | --- | | (State or Other Jurisdiction of | (I.R.S. Employer | | Incorpor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37899 SCWORX CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organizatio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37899 SCWORX CORP. (Exact name of registrant as specified in its charter) Delaware 47-5412331 (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37899 SCWORX CORP. (Exact name of registrant as specified in its charter) Delaware 47-5412331 (State or other jurisdiction of incorporatio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37899 SCWORX CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 47-5412331 | | --- | --- | | (State or Other Jurisdiction of | (I.R.S. Employer | | Incorpor ...